Can Higher HDL levels lead to reversion to normoglycemia from prediabetes?
China: An analysis based on data from a retrospective cohort study revealed an independent connection between high-density lipoprotein cholesterol (HDL-C) and regression to normoglycemia in Chinese adults with prediabetes, revealing a specific non-linear relationship and threshold effect.
In their study, published in Scientific Reports, the researchers observed a significant positive connection between HDL-C levels and the regression from Pre-DM to normoglycemia to normoglycemia, specifically when HDL-C levels were below the inflection point. Consequently, keeping HDL-C levels near the inflection point in prediabetes patients may greatly raise the likelihood of reversion from pre-DM to normoglycemia.
Higher HDL-C levels show a positive association with prediabetes reversal to normoglycemia in Chinese adults, but only up to a certain threshold, the researchers stated.
Prediabetes is characterized by a blood glucose level above the "normal" range but below the diagnostic threshold for type 2 diabetes (T2D). Previous studies have shown that even a temporary return to normal blood glucose levels in pre-DM patients is related to a significantly reduced chance of developing T2D. Therefore, it is important to highlight the significant clinical advantages of transitioning from Pre-DM to normoglycemia. The primary objective of screening and treating prediabetes should be to restore normoglycemia.
The available evidence on the connection between HDL-C levels and the reversion from prediabetes to normoglycemia is currently limited. Therefore, Yong Han, The First Affiliated Hospital of Shenzhen University, Shenzhen, Guangdong Province, China, and colleagues sought to investigate the connection between HDL-C levels and the regression from Pre-DM to normoglycemia in a population of Chinese adults.
The study included 15,420 prediabetes patients in China who underwent health screening between 2010 and 2016. The researchers investigated the connection between HDL-C levels and reversion from Pre-DM to normoglycemia using the Cox proportional hazards regression model.
The Cox proportional hazards regression model with cubic spline functions and smooth curve fitting was employed to ascertain the nonlinear association between HDL-C and reversion from prediabetes to normoglycemia. A set of sensitivity analyses and subgroup analyses were also employed.
The study led to the following findings:
- Following the adjustment of covariates, the findings revealed a positive connection between HDL-C levels and the likelihood of reversion from Pre-DM to normoglycemia (HR 1.898).
- There was a non-linear relationship between HDL-C and the reversion from Pre-DM to normoglycemia in both genders, and the inflection point of HDL-C was 1.540 mmol/L in males and 1.620 mmol/L in females.
- There was a strong positive correlation between HDL-C and the reversion from Pre-DM to normoglycemia on the left of the inflection point (Male: HR 2.783; Female: HR 2.217). The sensitivity analysis confirmed the robustness of these findings.
- Subgroup analyses indicated that patients with SBP < 140 mmHg and ever smoker exhibited a more pronounced correlation between HDL-C levels and the reversion from Pre-DM to normoglycemia.
- There was a less robust correlation among patients with SBP ≥ 140 mmHg, current and never smokers.
The study provides evidence of a positive and nonlinear association between HDL-C levels and the reversion from prediabetes to normoglycemia in Chinese patients.
"Implementing intensified intervention measures to control the HDL-C levels of prediabetes patients around the inflection point may substantially enhance the likelihood of regression to normoglycemia," the researchers concluded.
Reference:
Mo, Z., Hu, H., Han, Y., Cao, C., & Zheng, X. (2024). Association between high-density lipoprotein cholesterol and reversion to normoglycemia from prediabetes: An analysis based on data from a retrospective cohort study. Scientific Reports, 14(1), 1-14. https://doi.org/10.1038/s41598-023-50539-w
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd